Cited by 262DNA Repair MechanismsGenomics and Rare DiseasesNuclear Structure and Function

Cockayne syndrome: Clinical features, model systems and pathways

Open access
Karikkineth, Ajoy C., Scheibye-Knudsen, Morten, Fivenson, Elayne, Croteau, Deborah L., Bohr, Vilhelm A.·2017·Ageing Research Reviews

Abstract

Cockayne syndrome (CS) is a disorder characterized by a variety of clinical features including cachectic dwarfism, severe neurological manifestations including microcephaly and cognitive deficits, pigmentary retinopathy, cataracts, sensorineural deafness, and ambulatory and feeding difficulties, leading to death by 12 years of age on average. It is an autosomal recessive disorder, with a prevalence of approximately 2.5 per million. There are several phenotypes (1-3) and two complementation groups (CSA and CSB), and CS overlaps with xeroderma pigmentosum (XP). It has been considered a progeria, and many of the clinical features resemble accelerated aging. As such, the study of CS affords an opportunity to better understand the underlying mechanisms of aging. The molecular basis of CS has traditionally been ascribed to defects in transcription and transcription-coupled nucleotide excision repair (TC-NER). However, recent work suggests that defects in base excision DNA repair and mitochondrial functions may also play key roles. This opens up the possibility for molecular interventions in CS, and by extrapolation, possibly in aging.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.arr.2016.08.002

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Conditions with mutations in NER pathways include xeroderma pigmentosum (XP), Cockayne syndrome (CS), trichothiodystrophy (TTD), UV-sensitive syndrome (UV-SS), and cerebro-oculo-facioskeletal syndrome (COFS).

    “These include the conditions with mutations in NER pathways (presented in Table 3) such as xeroderma pigmentosum (XP) [149,150], Cockayne syndrome (CS) [151,152], trichothiodystrophy (TTD) [153,154,155,156], UV-sensitive syndrome (UV-SS), and cerebro-oculo-facioskeletal syndrome (COFS) [157,158,159].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 3

  1. Cheng A Yang Y Zhou Y Maharana C Lu D Peng W Liu Y Wan R Marosi K Misiak M Bohr VA Mattson MP 2016b Mitochondrial SIRT3 Mediates Adaptive Responses of Neurons to Exercise and Metabolic and Excitatory Challenges Cell Metab 23 128 142 10.1016/j.cmet.2015.10.013 26698917 PMC5141613 · DOI · Paper page
  2. Hyun M Lee J Lee K May A Bohr VA Ahn B 2008b Longevity and resistance to stress correlate with DNA repair capacity in Caenorhabditis elegans Nucleic Acids Res 36 1380 1389 10.1093/nar/gkm1161 18203746 PMC2275101 · DOI
  3. Traboulsi EI De Becker I Maumenee IH 1992b Ocular findings in Cockayne syndrome Am J Ophthalmol 114 579 583 1443019

Cited by

Sorted by citations

Authors
Karikkineth, A. C., Scheibye-Knudsen, M., Fivenson, E., Croteau, D. L., & Bohr, V. A.
Affiliations
  • National Institute on Aging (US)
  • National Institutes of Health (US)
Corresponding author
Bohr, Vilhelm A.
Venue
Ageing Research Reviews
Publisher
Elsevier BV
Published
2017-01
Volume
33
Pages
3-17
ISSN
1568-1637 (ISSN-L)
OpenAlex
W2500008420
Cited by
262
References
151
Citations by year
2026: 23 · 2025: 25 · 2024: 23 · 2023: 22 · 2022: 27 · 2021: 40 · 2020: 29 · 2019: 32 · 2018: 24 · 2017: 14 · 2016: 2
FWCI
2.17
Type
journal article
Language
en
Open access
Locations
  • Ageing Research Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • PubMed Central (acceptedVersion)
Funders
Intramural Research Program of the NIH, National Institute on Aging
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
Keywords
Cockayne syndrome, transcription-coupled repair, DNA base excision repair, mitochondrial dysfunction, accelerated aging, Hutchinson-Gilford progeria syndrome, xeroderma pigmentosum, dwarfism, microcephaly, pigmentary retinopathy, sensorineural hearing loss, complementation groups, model systems, aging mechanisms
MeSH terms
Aging, Animals, Cockayne Syndrome, Cognition, DNA Repair, Humans, Mitochondria, Models, Biological, Transcriptional Activation, Aging, Premature, Symptom Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review